Generated by AI
Omnicell, Inc. is a healthcare technology company that provides medication management solutions and adherence tools for hospitals, health systems, retail pharmacies, and other care settings. Omnicell’s portfolio includes automated dispensing systems, central pharmacy automation, robotic dispensing, IV compounding, inventory management software, and point-of-care solutions designed to streamline medication workflows and support safer medication handling. The company also offers patient engagement and medication adherence tools through its EnlivenHealth brand, helping pharmacies and providers manage prescriptions, packaging, and communication more efficiently. Omnicell’s products and services are used across inpatient, outpatient, post-acute, and retail environments, where they support clinical teams with automation, analytics, and workflow integration. The company plays a notable role in healthcare operations by helping organizations improve medication management across the care continuum.
Website4220 North Freeway
Fort Worth, TX, 76137
United States
The latest articles about OMCL.
CNK, FANG and OMCL gain momentum from upward broker rating revisions, backed by strong projected 2026 earnings growth.
AVT, OMCL, HPE and LCUT stand out as undervalued stocks, backed by strong earnings surprises, attractive valuations and robust projected growth.
Summary of Apr 28's posts. Generated by AI.
No summary yet.
Summary of Apr 28's posts. Generated by AI.
Summary of Apr 28's posts. Generated by AI.
Investors talking about OMCL also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.